2012 HCPCS G9100
Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)

  • This is the 2012 version of HCPCS G9100 - please refer to the 2016 HCPCS code set for the latest version.
  • Added on Sunday, January 01, 2006
  • Status changed on Monday, January 01, 2007 to: No maintenance for this code
  • BETOS Classification: Oncology > Other
  • Medicare coverage status: Carrier judgment

  G9099    G9101